Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

According to the Daily Mail, patients who take the weight-loss shots were twice as likely to suffer from a serious ...

An SGLT2 inhibitor helped improve metabolic dysfunction-associated steatohepatitis (MASH) in people with or without type 2 ...

Dr Sof Andrikopoulos explains why moderation is key to prevention—and how new therapies are changing the game in diabetes ...

Nearly 16 million Americans have the most deadly type of liver disease - metabolic dysfunction-associated steatohepatitis ...

Don’t be persuaded by the abundance of propaganda you see in ads, newspapers, magazines, TV, and the Internet. There is no ...

Clash over calls to prescribe weight loss drugs for life - despite concerns over side effects, and dramatic weight regain ...

GLP-1s are gaining interest for their impact on weight, blood sugar, and possibly mood in bipolar disorder. Here’s what ...